About us

AI-driven technology for medicine

Founded in 2019 and headquartered in San Diego, Entos is advancing a small-molecule therapeutics pipeline using AI-driven high-throughput experimentation.

The Entos team is comprised of renowned scientists and engineers with world-class expertise in machine learning, automation, medicinal chemistry, analytical chemistry, and biology.

Join our team
Our investment partners

Company Board

Tom Miller

CEO at Entos

Fred Manby

CTO at Entos

Jishnu Bhattacharjee

Managing Director at Nexus Venture Partners

Jacob Vogelstein

Co-founder and Managing Partner at Catalio Capital Management LP

Aaron Weiner

Managing Director and Head of Healthcare at Coatue

Leadership

Lorem ipsum dolor sit amet, consectetur adipiscing elit. At mattis rutrum sed tempor ullamcorper eget ut morbi quis.

Mary Anderson
SVP, Business Development
Linkedin
Laurent Gomez
VP, Discovery chemistry
Linkedin
Jeanne Grover
Director, Finance and Operations
Linkedin
John Huang
VP, Biology
Linkedin
Fred Manby
CTO
Linkedin
Tom Miller
CEO
Linkedin
José Quiroz
Executive Director, HTE Operations
Linkedin
Daniel Smith
Director, Software
Linkedin
Tabbert Teng
VP, Finance
Linkedin
Matt Welborn
Director, Machine Learning
Linkedin
Chao Zhang
CSO
Linkedin
Hui Zhang
VP, Analytical Technologies
Linkedin

Scientific Advisory Board

Lorem ipsum dolor sit amet, consectetur adipiscing elit. At mattis rutrum sed tempor ullamcorper eget ut morbi quis.

Frances Arnold

Nobel Prize in Chemistry. Linus Pauling Professor at Caltech. Member of President's Science and Tech Advisory Board and Alphabet Board of Directors.

Derek Lowe

Director in Chemical Biology Therapeutics at Novartis, and author of In the Pipeline at Science Magazine.

Nick Saccomano

Former CSO/SVP at Pfizer Boulder and former CSO, Array Biopharma.

Connor Coley

Assistant Professor of Chemical Engineering at Massachusetts Institute of Technology.

Jack Taunton

Professor of Cellular Molecular Pharmacology at UCSF, co-founder of Cedilla, Principia Biopharma, GBT, Kezar.

Ken Brameld

Senior Advisor for Samsara Biocapital, and former SVP Head of Research, Principia Biopharma.

Scientific advisory board

We are actively supported through our distinguished network of scientific and business advisors.

Frances Arnold

Nobel Prize in Chemistry. Linus Pauling Professor at Caltech. Member of President's Science and Tech Advisory Board and Alphabet Board of Directors.

Connor Coley

Assistant Professor of Chemical Engineering at Massachusetts Institute of Technology.

Derek Lowe

Director in Chemical Biology Therapeutics at Novartis, and author of In the Pipeline at Science Magazine.

Jack Taunton

Professor of Cellular Molecular Pharmacology at UCSF, co-founder of Cedilla, Principia Biopharma, GBT, Kezar.

Ken Brameld

Senior Advisor for Samsara Biocapital, and former SVP Head of Research, Principia Biopharma.

Nick Saccomano

Former CSO/SVP at Pfizer Boulder and former CSO, Array Biopharma.

Scientific collaborators

Lorem ipsum dolor sit amet consectetur adipiscing elit ultrices blandit duis lorem elementum lacinia

Anima Anandkumar

Bren Professor of Computing at Caltech.

Mission

Collaborative discovery

We're building a diverse team of scientists and technologists to transform the discovery of small molecule therapeutics for patients with cancer.

We liberate our people to innovate, collaborate, and problem-solve. We emphasize productive communication networks, and we believe that every team member can and should play a role in helping others perform at their best.

Our core values are:

  • Innovation through collaboration and respecting different view-points
  • Continuously supporting each other to do our best work
  • Giving each person the autonomy to tackle the biggest challenges
Join our team

Headquartered in San Diego

Our headquarters and state-of-the-art laboratory facilities are located in La Jolla on the UCSD Science Research Park